Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
12 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/12/3131762/0/en/LiveWorld-Reports-Second-Quarter-2025-Financial-Results.html
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103335/0/en/Chiesi-Global-Rare-Diseases-Awards-Research-Grants-to-Advance-Innovation-in-Lysosomal-Diseases.html
19 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250619863550/en/Chiesi-Global-Rare-Diseases-Awards-Research-Grants-to-Advance-Innovation-in-Lysosomal-Diseases
03 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-multiple-presentations-at-21st-annual-worldsymposium-research-meeting-302366139.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-and-protalix-biotherapeutics-announce-validation-of-variation-submission-by-european-medicines-agency-for-pegunigalsidase-alfa-302325589.html
28 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-publication-of-results-from-phase-3-bright-study-of-elfabrio-pegunigalsidase-alfa-iwxj-in-fabry-disease-302287880.html
ABOUT THIS PAGE